SyFungin (Syntrion GmbH)
Welcome to the PulseAid listing for the SyFungin drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Syntrion GmbH |
NON-PROPRIETARY NAME: | CANDIDA PARAPSILOSIS |
SUBSTANCE NAME: | CANDIDA PARAPSILOSIS |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2014-10-15 |
END MARKETING DATE: | 2019-09-30 |
SyFungin HUMAN OTC DRUG Details:
Item Description | SyFungin from Syntrion GmbH |
LABELER NAME: | Syntrion GmbH |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2014-10-15 |
END MARKETING DATE: | 2019-09-30 |
PRODUCT ID: | 10424-105_20fab166-f103-4749-94a5-e3e909ac2ed8 |
PRODUCT NDC: | 10424-105 |
APPLICATION NUMBER: | |
Other CANDIDA PARAPSILOSIS Pharmaceutical Manufacturers / Labelers: